Pay in 4 interest-free payments of $33.27 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
InChi: InChI=1S/C18H31NO4
placebo-controlled Phase 1/2a trial for patients with open angle glaucoma or ocular hypertension
950762-95-5
SB505124 susspresses CTGF and α-SMA observed by immunofluorescence
Inhibition of NAALADase by 2-PMPA attenuates cocaine-induced relapse in rats: a NAAG-mGluR2/3-mediated mechanism
Istaroxime Catalog No.:M9594-10 InChi: InChI=1S/C18H31NO4Istaroxime, also known as PST 2744, is a positive inotropic agent that mediates its action through inhibition of sodium potassium adenosine triphosphatase (Na+ K+ ATPase). Na+ K+ ATPase inhibition increases intracellular sodium levels, which reverses the driving force of the sodium calcium exchanger, inhibiting calcium extrusion and possibly facilitating calcium entry. Additionally, Istaroxime increases intracellular calcium by improving the efficacy
US$ 188.00
US$ 114.00
US$ 119.00
US$ 134.20
US$ 290.00
US$ 198.00
US$ 153.50
US$ 154.50
US$ 111.00
US$ 182.00